Close this search box.


Loading Events

A New Standard of Care: The Role of SGLT2i in Type 2 Diabetes

Join us on Thursday, 23 November 2023 from 7:00 pm to 8:00 pm (AEDT) as we discuss the following in relation to the role of SGLT2 inhibitors in type 2 diabetes:

  • The benefits of SGLT2i on glycaemia, CVD and CLD
  • The benefits of early glycaemic management of type 2 diabetes
  • Addressing the barriers for SGLT2i use in type 2 diabetes
  • The ideal situation for SGLT2i initiation


Click here to view the event flyer.
Click here to register for the webinar.

This webinar is registered for 1 CPD hour with the RACGP CPD Program and certificate of attendance available upon request.

For any further information please contact the ADS Secretariat via email to

Boehringer Ingelheim Logo     Lilly Logo
The ADS gratefully acknowledges the support from Boehringer Ingelheim and Lilly for this educational diabetes webinar.